BamSEC and AlphaSense Join Forces
Learn More

Mangoceuticals Inc. – Material Contracts

NASDAQ: MGRX    
Share price (6/8/26): $0.36    
Market cap (6/8/26): $6.232 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q 2 pages Clarification Agreement
12/34/56
EX-10.1
from 8-K 2 pages Mangoceuticals, Inc. Amendment to Stock Option Agreements
12/34/56
EX-10.3
from 8-K 24 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 13 pages Personal and Confidential Mr. Jacob Cohen, Chief Executive Officer Mangoceuticals, Inc. 17130 N. Dallas Parkway, Suite 240 Dallas, Texas 75248 Re: MGRX | Registered Direct and Pipe Offering | Placement Agent Agreement Dear Mr. Cohen
12/34/56
EX-10.1
from 8-K 48 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 3 pages Order Form
12/34/56
EX-10.1
from 8-K 16 pages Master Service Agreement
12/34/56
EX-10.1
from 8-K 11 pages Promissory Note
12/34/56
EX-10.2
from 8-K 10 pages Separation Agreement
12/34/56
EX-10.1
from 8-K 40 pages Lease Between Svhq, LLC (“Landlord”) and Mangoceuticals, Inc (“Tenant”) Lease
12/34/56
EX-10.2
from 8-K 12 pages Mangoceuticals, Inc. 2022 Equity Incentive Plan Stock Option Agreement
12/34/56
EX-10.1
from 8-K 27 pages Subscription Agreement in Mangoceuticals, Inc
12/34/56
EX-10.1
from 8-K 6 pages Mutual Rescission and Release Agreement
12/34/56
EX-10.3
from 8-K 13 pages Amended and Restated Convertible Promissory Note
12/34/56
EX-10.2
from 8-K 6 pages Agreement to Amend Promissory Note
12/34/56
EX-10.3
from 8-K 14 pages Amended and Restated Convertible Promissory Note
12/34/56
EX-10.2
from 8-K 6 pages Agreement to Amend Promissory Note
12/34/56
EX-10.1
from 8-K 32 pages Instructions to Investors
12/34/56
EX-10.3
from 8-K 8 pages Mutual Rescission and Release Agreement Page 1 of 8
12/34/56
EX-10.2
from 8-K 8 pages Mutual Rescission and Release Agreement
12/34/56